-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Ardent Health, Raises Price Target to $22

Benzinga·11/17/2026 14:35:07
Listen to the news
Truist Securities analyst David Macdonald maintains Ardent Health (NYSE:ARDT) with a Buy and raises the price target from $13 to $22.